-
1.发明申请公开(公告)号：US20250120992A1
公开(公告)日：2025-04-17
申请号：US18823345
申请日：2024-09-03
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Wanki KIM , Jong Hwa ROH
IPC: A61K31/7048 , A61K31/353 , A61P1/16
Abstract: This specification discloses a method for improving liver health, including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin effectively reduces oxidative stress and chronic inflammatory reaction that occurs during accumulation of lipids in liver tissue, thereby making it possible to enhance liver health and prevent, improve, or treat various liver diseases such as hepatitis, cirrhosis, and liver cancer.
-
公开(公告)号：US20250120940A1
公开(公告)日：2025-04-17
申请号：US18883218
申请日：2024-09-12
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Wanki KIM , Jong Hwa ROH
IPC: A61K31/353 , A61K31/7048
Abstract: A method for improving fatigue, exercise performance, or endurance, the method including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof is disclosed. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin can effectively inhibit accumulation of lactic acids in muscle cells and significantly increase mitochondria in the cells.
-
公开(公告)号：US20240189386A1
公开(公告)日：2024-06-13
申请号：US18515425
申请日：2023-11-21
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC classification number: A61K38/168 , A61K36/82 , A61K38/08 , A61K38/10 , A61P19/00 , A61K2236/19 , A61K2236/333 , A61K2236/39
Abstract: The present disclosure relates to a composition for anti-fatigue comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure exhibits anti-fatigue efficacy through excellent effects of inhibiting production of fatigue substances within a muscle cell, increasing ATP production within the muscle cell, and promoting fat oxidation within the muscle cell, and can be applied to various health functional food compositions and pharmaceutical compositions.
-
4.发明申请公开(公告)号：US20250120993A1
公开(公告)日：2025-04-17
申请号：US18883178
申请日：2024-09-12
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Wanki KIM , Jong Hwa ROH
IPC: A61K31/7048 , A61K31/353 , A61P3/08
Abstract: A method for controlling blood sugar, including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof is disclosed. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin can effectively inhibit gluconeogenesis in liver cells and effectively improve transport of glucose in differentiated fat cells and liver cells, thereby exhibiting excellent blood sugar control efficacy.
-
5.发明公开公开(公告)号：US20240226223A1
公开(公告)日：2024-07-11
申请号：US18536404
申请日：2023-12-12
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC classification number: A61K36/82 , A61K38/168 , A61P21/00 , A61K2236/19 , A61K2236/331 , A61K2236/333
Abstract: The present disclosure relates to a composition for preventing, improving, or treating muscle loss comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure may exhibit an efficacy in preventing, improving, or treating muscle loss through the excellent effects of increasing protein synthesis in muscle cells and inhibiting protein degradation in the muscle cells, and thus may be applied in various health functional food compositions and pharmaceutical compositions.
-
Patent Agency Ranking
公开(公告)号：US20230381262A1
公开(公告)日：2023-11-30
申请号：US18325484
申请日：2023-05-30
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
IPC: A61K36/82 , A61P29/00 , A23L33/105 , A23L2/52 , A23L33/00
CPC classification number: A61K36/82 , A61P29/00 , A23L33/105 , A23L2/52 , A23L33/40
Abstract: A method for reducing absorption of a microplastic in a body, including administering a composition including an effective amount of a green tea extract to a subject in need thereof is disclosed in the specification. One aspect of the present disclosure is the composition may be a food composition or a pharmaceutical composition.
-
公开(公告)号：US20210308166A1
公开(公告)日：2021-10-07
申请号：US17266567
申请日：2019-07-02
Applicant: AMOREPACIFIC CORPORATION
Inventor： Yong Deog HONG , Hyun Woo JEONG
IPC: A61K31/7048 , A61K36/258 , A61K31/7016 , A61K8/9789 , A23L33/105 , A61P39/06 , A61Q19/00
Abstract: The present specification relates to a composition comprising (20S,24R)-6-O-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, and pharmaceutically acceptable salts thereof, a hydrate thereof or a solvate thereof as an active ingredient. The composition exhibits an excellent antioxidant effect.
-
公开(公告)号：US20240181002A1
公开(公告)日：2024-06-06
申请号：US18515599
申请日：2023-11-21
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC classification number: A61K38/168 , A61P3/04 , A61K2236/19 , A61K2236/333 , A61K2236/37
Abstract: The present disclosure relates to a composition for anti-obesity including a green tea peptide composition. Specifically, the green tea peptide composition according to the one aspect of the present disclosure exhibits anti-obesity efficacy through excellent lipid metabolism activation and can be applied to various health functional food compositions and pharmaceutical compositions.
-
公开(公告)号：US20210309693A1
公开(公告)日：2021-10-07
申请号：US17267666
申请日：2019-06-27
Applicant: AMOREPACIFIC CORPORATION
Inventor： Yong Deog HONG , Hyun Woo JEONG
IPC: C07J17/00 , A61K8/63 , A23L33/105 , A61Q19/00 , A61K9/00
Abstract: The present specification relates to (20S,24R)-6-O-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel ginsenoside exhibits excellent anti-inflammatory effects.
-
10.发明申请公开(公告)号：US20180271830A1
公开(公告)日：2018-09-27
申请号：US15989544
申请日：2018-05-25
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Jung SHIN , Hyun Woo JEONG , Ji Hae LEE , Dae Jin MIN , Dae Bang SEO , Sang Jun LEE
CPC classification number: A61K31/37 , A23V2002/00 , A61K36/48 , A61K2236/19
Abstract: The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.
-
-
-
-
-
-
-
-
-
Search Results
23
records
(took 0.02 seconds)
